Jubilant Ingrevia Share Price

NSE
786.55
+104.55 (14.17%)
JUBLINGREA • 13 Jun, 2025 | 03:29 PM
BUY

1Y Annualised Return

32.29%

3Y Annualised Return

13.17%

The current prices are delayed, login or Open Demat Account for live prices.

Jubilant Ingrevia SIP Return Calculator

Over the past

1 year
3 years

Total Investment of ₹65,00,000

Would have become ₹76,76,070 (+18.09%)

Daily SIP of 25,000 would have become 76,76,070 in 1 year with a gain of 11,76,070 (+18.09%)

Jubilant Ingrevia Stock Performance
Today’s Low - High
690.00
806.00
690.00
806.00
52 Week Low - High
502.80
885.00
502.80
885.00

Open

692.00

Prev. Close

682.00

Total Traded Value

2130.83 Cr

View details of Market Depth
Jubilant Ingrevia Fundamental

Market Cap (in crs)

12,639.75

Face Value

1

Turnover (in lacs)

2,13,083.42

Key Metrics
Qtr Change %
57.83% Gain from 52W Low
17
Dividend yield 1yr %
Above industry Median
0.6

Jubilant Ingrevia Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Jubilant Ingrevia Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
1051.26 Cr
1056.77 Cr
1045.24 Cr
1024.34 Cr
1074.44 Cr

Jubilant Ingrevia Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
4215.43 Cr
4171.1 Cr
4806.06 Cr
4980.85 Cr
686.73 Cr

Jubilant Ingrevia Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
74.02 Cr
69.37 Cr
59 Cr
48.66 Cr
29.3 Cr

Jubilant Ingrevia Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
251.19 Cr
182.87 Cr
307.53 Cr
476.76 Cr
54.36 Cr
-0.17 Cr
Jubilant Ingrevia Result Highlights
  • Jubilant Ingrevia Ltd reported a 1.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 6.1%.

  • Its expenses for the quarter were up by 6.4% QoQ and down 4.3% YoY.

  • The net profit decreased 57.8% QoQ and decreased 44.1% YoY.

  • The earnings per share (EPS) of Jubilant Ingrevia Ltd stood at 1.9 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Jubilant Ingrevia shareholding Pattern

Promoter
51.5%
Foreign Institutions
7.1%
Mutual Funds
14.1%
Domestic Institutions
15.9%
Public
24.8%
Promoter
51.5%
Foreign Institutions
6.9%
Mutual Funds
13.9%
Domestic Institutions
16%
Public
24.9%
Promoter
51.5%
Foreign Institutions
7.2%
Mutual Funds
12.7%
Domestic Institutions
15.5%
Public
25.1%
Promoter
51.5%
Foreign Institutions
6.6%
Mutual Funds
10.6%
Domestic Institutions
14%
Public
27.1%
Promoter
51.5%
Foreign Institutions
6.6%
Mutual Funds
10.2%
Domestic Institutions
13.6%
Public
27.5%
Promoter
51.5%
Foreign Institutions
6.4%
Mutual Funds
9.1%
Domestic Institutions
11.1%
Public
30.2%

Jubilant Ingrevia Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
786.55
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
725.80
10Day EMA
715.10
12Day EMA
712.80
20Day EMA
706.20
26Day EMA
702.30
50Day EMA
693.90
100Day EMA
692.20
200Day EMA
678.00
5Day SMA
711.40
10Day SMA
715.60
20Day SMA
702.40
30Day SMA
699.80
50Day SMA
683.00
100Day SMA
680.60
150Day SMA
708.70
200Day SMA
713.50
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
2631218 Rs
28319481 Rs
Week Rs
704986 Rs
5996923 Rs
Month Rs
305770 Rs
1690530 Rs
Resistance & Support
763.18
Pivot
Resistance
First Resistance
836.37
Second Resistance
879.18
Third Resistance
952.37
Support
First Support
720.37
Second support
647.18
Third Support
604.37
Relative Strength Index
68.78
Money Flow Index
92.45
MACD
10.50
MACD Signal
7.52
Average True Range
33.54
Average Directional Index
24.79
Rate of Change (21)
15.42
Rate of Change (125)
-6.64
Shareholding
Name
Holding Percent
DSP SMALL CAP FUND
9.37
EDELWEISS TRUSTEESHIP CO LTD AC- EDELWEISS MF AC-EDELWEISS SMALL CAP FUND
1.07
FRANKLIN INDIA SMALLER COMPANIES FUND
1

Jubilant Ingrevia Latest News

13 JUN 2025 | Friday

Jubilant Ingrevia Ltd - 543271 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

13 JUN 2025 | Friday

Broker's call: Jubilant Ingrevia (Hold)

06 JUN 2025 | Friday

Jubilant Ingrevia Ltd - 543271 - Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024, As Amended

View More

Jubilant Ingrevia Company background

Founded in: 2019
Managing director: Mr. Deepak Jain
Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh. The name of the Company was changed from Jubilant LSI Limited to Jubilant Ingrevia Limited on October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, costeffective and conforming to excellent quality standards. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges Jubilant Ingrevia Limited, Jubilant Pharmova Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. The Companys stateoftheart manufacturing facilities across India offer a range of products and solutions that are innovative, costeffective and quality driven. It established itself as a single point solution for CDMO services for global Pharmaceutical and Agrochemical companies. It is at present across the value chain like Route design, Process Development, Process Optimisation, Scaleup and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. It is a leading supplier of Ethanol to Oil Marketing Companies (OMCs) for Ethanol Blending Programme (EBP) among standalone distilleries in India. The Company is engaged in manufacturing and supply of speciality intermediates, nutrition health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the Company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The business focuses on three core segments Speciality Chemicals, Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and Indias largest manufacturer of Vitamin B4. The Company is a Partner of Choice for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand Phytoshield. The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date.During FY 202223, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.The Company launched new products by introducing the foodgrade Choline Chloride and Choline Bitartrate in FY24. Further, a new agrochemical plant at SEZ Bharuch commissioned in FY 2024. The Phase II of Diketene Derivatives with the addition of 2000 TPA for multiple products was commissioned. A multipurpose Agro Actives Intermediate plant in Bharuch and a Diketene Derivatives plant in Gajraula commissioned in FY24.

As of 13 Jun, 2025, JUBLINGREA share price is ₹793.6. The stock opened at ₹692 and had closed at ₹682 the previous day. During today’s trading session, JUBLINGREA share price moved between ₹690.00 and ₹806.00, with an average price for the day of ₹748.00. Over the last 52 weeks, the stock has recorded a low of ₹502.80 and a high of ₹885.00. In terms of performance, JUBLINGREA share price has declined by 4.8% over the past six months and has increased by 32.29% over the last year.

Read More

Jubilant Ingrevia FAQs

Jubilant Ingrevia share price is ₹786.55 in NSE and ₹782.05 in BSE as on 13/6/2025.

Jubilant Ingrevia share price in the past 1-year return was 53.92. The Jubilant Ingrevia share hit a 1-year low of Rs. 502.8 and a 1-year high of Rs. 885.

The market cap of Jubilant Ingrevia is Rs. 12639.75 Cr. as of 13/6/2025.

The PE ratios of Jubilant Ingrevia is 47.95 as of 13/6/2025.

The PB ratios of Jubilant Ingrevia is 5.17 as of 13/6/2025

The Mutual Fund Shareholding in Jubilant Ingrevia was 14.1% at the end of 13/6/2025.

You can easily buy Jubilant Ingrevia shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Jubilant Ingrevia stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -